Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001836354-25-000003
Filing Date
2025-08-12
Accepted
2025-08-12 17:50:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2809
  Complete submission text file 0001836354-25-000003.txt   4448
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Subject) CIK: 0001341235 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36332 | Film No.: 251208242
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address
Machatha Stephen (Reporting) CIK: 0001836354 (see all company filings)

Type: 144